Based in the United States, eNeura is a startup. Brouky records 2 investors associated with the company.
eNeura develops and commercializes FDA-cleared single-pulse transcranial magnetic stimulation (sTMS) devices for the acute and preventive treatment of migraine in patients 12 years and older.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.